Alliance for Hippocratic Medicine, a group of anti-abortion medical organizations, alleges the FDA failed to adequately ... It ordered prior drug safety restrictions reinstated.
The Food and Drug Administration is making plans to significantly expand the number of gay and bisexual men who could donate sperm anonymously. Longstanding agency rules ban anonymous sperm ...
But there was more to the tweet than a zoological judgment. The FDA’s goal was to advise individuals against taking ivermectin, a medication used to treat parasitic infections in livestock ...
Most immediately, a decision that rolls back the FDA’s changes would reimpose all the prescribing restrictions once placed on mifepristone, even though they are not medically necessary.
Unfortunately, the label for eplerenone will place more stringent restrictions on its use than is the case for spironolactone. The basis for the multiple contraindications to the use of eplerenone ...
Food and Drug Administration (FDA) Commissioner Dr. Robert Califf testifies on oversight matters before the House Oversight and Accountability Committee. General Services Administration (GSA ...
The FDA is set to axe its ban on gay and bisexual men donating sperm, it has been revealed. Under the current rule, men who have had sex with men within the last five years are blocked from ...
Jamie Raskin, D-Md., ranking member of the committee, asked the FDA what it plans to do regarding many products, including lead-contaminated cinnamon applesauce pouches that caused many children ...
Less than two years after the Supreme Court overturned Roe v. Wade, the issue of reproductive rights is returning to the high court on Tuesday as the justices consider whether to limit access to a ...
In August 2021, to discourage people from using ivermectin to prevent or treat Covid-19, the FDA tweeted “You are not a horse. You are not a cow. Serious y’all. Stop It.” and posted a ...
Today, 85% of accelerated approvals go to cancer drugs. It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases.
One member of the FDA advisory committee was linked to hundreds of payments from Abbott totaling almost $200,000, according to a database maintained by the Department of Health and Human Services.